Moors & Cabot’s AllianzIM U.S. Equity Buffer20 Jan ETF JANW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$336K Sell
8,500
-250
-3% -$9.8K 0.01% 711
2026
Q2
$338K Sell
8,750
-400
-4% -$15.2K 0.01% 705
2026
Q1
$334K Buy
9,150
+1,250
+16% +$46.3K 0.01% 667
2025
Q4
$292K Hold
7,900
– – 0.01% 692
2025
Q3
$286K Hold
7,900
– – 0.01% 688
2025
Q2
$276K Sell
7,900
-500
-6% -$16.8K 0.01% 682
2025
Q1
$279K Buy
8,400
+1,800
+27% +$60.8K 0.01% 661
2024
Q4
$222K Sell
6,600
-1,700
-20% -$56.6K 0.01% 773
2024
Q3
$273K Sell
8,300
-500
-6% -$16.2K 0.01% 683
2024
Q2
$283K Sell
8,800
-500
-5% -$15.8K 0.02% 647
2024
Q1
$292K Buy
+9,300
New +$287K 0.02% 681

Other funds holding JANW

Moors & Cabot's JANW Position: Q3 2026 in Review

Moors & Cabot reduced its AllianzIM U.S. Equity Buffer20 Jan ETF (JANW) stake by 2.9% in Q3 2026, selling an estimated $9.8K and leaving 8,500 shares worth $336K. The position accounts for 0.01% of the portfolio, ranked #711.

Moors & Cabot first reported a position in JANW in Q1 2024 and has held it in 11 quarters since. The position peaked at $338K in Q2 2026. 56 funds tracked by Wall St. Rank hold JANW as of Q3 2026.

  • Moors & Cabot held 8,500 shares of AllianzIM U.S. Equity Buffer20 Jan ETF worth $336K as of Q3 2026.
  • Moors & Cabot sold 250 AllianzIM U.S. Equity Buffer20 Jan ETF shares in Q3 2026, an estimated $9.8K.
  • AllianzIM U.S. Equity Buffer20 Jan ETF made up 0.01% of Moors & Cabot's portfolio in Q3 2026, its #711 holding.
  • Moors & Cabot first reported a position in AllianzIM U.S. Equity Buffer20 Jan ETF in Q1 2024 and has held it in 11 quarters since.
  • Moors & Cabot's AllianzIM U.S. Equity Buffer20 Jan ETF position peaked at $338K in Q2 2026.
  • 56 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Jan ETF as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.